Assertio Holdings, Inc.(ASRT)Stock Analysis

ASRT Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Assertio Holdings, Inc. (ASRT), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ASRT at 27.2/100 on a 32-signal composite quality model, placing it at rank #2,471 of 2,879 stocks — the bottom half of the AI-ranked universe. ASRT scores in the top quartile across institutional flow (99.9). Areas of concern include revenue growth (10.2) and profitability (14.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 34.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Assertio Holdings, Inc. reports quarterly revenue of $9.9M, net income of $-18.9M, free cash flow of $8.6M. Top institutional holders of ASRT by reported 13-F value include Context Capital Management,, Nantahala Capital Management,, OAKTREE CAPITAL MANAGEMENT, based on the most recent SEC filings. ASRT trades on the Nasdaq exchange and files with the SEC under CIK 1808665. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ASRT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Assertio Holdings, Inc. directly from SEC EDGAR.